Does TRILACICLIB Cause Deep vein thrombosis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Deep vein thrombosis have been filed in association with TRILACICLIB (COSELA). This represents 2.7% of all adverse event reports for TRILACICLIB.
6
Reports of Deep vein thrombosis with TRILACICLIB
2.7%
of all TRILACICLIB reports
1
Deaths
5
Hospitalizations
How Dangerous Is Deep vein thrombosis From TRILACICLIB?
Of the 6 reports, 1 (16.7%) resulted in death, 5 (83.3%) required hospitalization.
Is Deep vein thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRILACICLIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TRILACICLIB Cause?
Off label use (25)
Myelosuppression (24)
Dyspnoea (18)
Pneumonia (18)
White blood cell count decreased (18)
Platelet count decreased (17)
Anaemia (15)
Performance status decreased (14)
Death (13)
Infection (12)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which TRILACICLIB Alternatives Have Lower Deep vein thrombosis Risk?
TRILACICLIB vs TRILEPTAL
TRILACICLIB vs TRIMEBUTINE
TRILACICLIB vs TRIMEPRAZINE
TRILACICLIB vs TRIMETAZIDINE
TRILACICLIB vs TRIMETHOBENZAMIDE